Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

Among them, WW International (WW), formerly known as WeightWatchers, hit a rough patch earlier this year, resulting in WW ...

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...

On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...

A labeling mistake has led to a nationwide recall of four different types of Ritz peanut butter cracker sandwich cartons, ...

An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...

Whether you were in favor of President Donald Trump's One Big Beautiful Bill or against it, what is more important now is how the new legislation will affect you. It can pay to dig a bit deeper into ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...